News
- Author:
- Andrew D. Bowser
Publish date: August 14, 2019
A long-term survival benefit was seen in about a third of patients with metastatic or unresectable melanoma who underwent first-line treatment with...
Article
- Author:
- Andrew D. Bowser
Publish date: July 25, 2019
Potent, first-in-class antiretroviral drug may eventually allow for once-weekly or once-monthly dosing, investigator says.
News
- Author:
- Andrew D. Bowser
Publish date: July 25, 2019
The long-term islatravir implant could one day provide an easier adherence alternative for many.
Article
- Author:
- Andrew D. Bowser
Publish date: July 24, 2019
In light of these findings and those from other studies, it may be time to “rethink the position of dual therapy in the international guidelines.”<...
News
- Author:
- Andrew D. Bowser
Publish date: July 22, 2019
Higher success rate, but also a higher rate of reflux esophagitis, seen in patients with previously untreated achalasia.
News
- Author:
- Andrew D. Bowser
Publish date: July 22, 2019
WHO recommends DTG as preferred first-line agent following release of updated Tsepamo study results.
News
- Author:
- Andrew D. Bowser
Publish date: July 22, 2019
Incidence increased from 10% to 12% over a decade in the analysis of a large U.S. cancer registry.
News
- Author:
- Andrew D. Bowser
Publish date: July 17, 2019
Diastolic hypertension can’t be ignored, investigator says, though systolic ultimately has a larger impact.
News
- Author:
- Andrew D. Bowser
Publish date: July 15, 2019
Weight loss or BMI-based dosing might improve treatment response.
News
- Author:
- Andrew D. Bowser
Publish date: July 10, 2019
Fewer prescriptions, less reported antibiotic use, with no evidence of harm or reduced quality of life, according to PACE trial investigators.
News
- Author:
- Andrew D. Bowser
Publish date: July 9, 2019
In a randomized clinical trial of 1,846 adults who had undergone autologous HSCT, herpes zoster cases were seen in 49 and 136 individuals in the va...
News
- Author:
- Andrew D. Bowser
Publish date: July 9, 2019
MILAN – Safety, mode of action, and price are just a few variables that distinguish these molecules in the ring.
News
- Author:
- Andrew D. Bowser
Publish date: July 8, 2019
Odds of adverse events increased by 5% per excess day of antibiotic treatment.
News
- Author:
- Andrew D. Bowser
Publish date: July 1, 2019
Elderly patients with no or low CAC, low galectin-3, or no carotid plaque, have a low risk of atherosclerotic car...
News
- Author:
- Andrew D. Bowser
Publish date: July 1, 2019
High levels of lipoprotein(a) [Lp(a)] and LPA genotypes were linked to increased ischemic stroke risk in a recent large, contemporary general popul...
